New rapid test for sperm damage may predict embryonic aneuploidy and improve reproductive outcomes

A rapid diagnostic method for double-strand breaks (DSBs), Sperm deoxyribonucleic acid (DNA) Fragmentation (SDF) Releasing Assay (SDFR).

Topical Treatment for Epidermolysis Bullosa Wins FDA Approval

The FDA approved birch triterpenes (Filsuvez) topical gel for the treatment of epidermolysis bullosa (EB), Chiesi Global Rare Diseases announced on Tuesday. The approval stipulates

December 20, 2023

New hope for stroke patients: University of Cincinnati trial tests unique tongue exercise device

The Gardner Neuroscience Institute, supported by a $660,000 NIH grant, is launching a trial to test an at-home tongue endurance exercise aimed at improving swallowing

January 11, 2024

Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data

Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.